secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker VCYT CIK 0001384101
earnings confidence high sentiment positive materiality 0.75

Veracyte Q1 2026 revenue $139.1M (+21% YoY); GAAP net income $28.7M, adj. EBITDA $42.8M

VERACYTE, INC.

2026-Q1 EPS reported $0.35 revenue$139,071,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

VERACYTE, INC. reported first quarter ended March 31, 2026 results: revenue $139.1 million, net income $28.7 million.

Period
first quarter ended March 31, 2026
Revenue
$139.1 million
Net income
$28.7 million
Result
reported results
Exact text from the filing
Key Financial Highlights For the three-month period ended March 31, 2026, as compared to the same period in 2025: • Increased total revenue by 21% to $139.1 million and testing revenue by 26% to $135.1 million, driven by Decipher growth of 30% to $86.5 million and Afirma growth of 21% to $46.4 million. • Increased total volume by 17% to 47,615 tests and testing volume by 19% to 45,248 tests, driven by Decipher growth of 24% to approximately 28,000 tests and Afirma growth of 12% to approximately 17,200 tests. • Recorded GAAP net income of $28.7 million, or 20.6% of revenue, and delivered adjusted EBITDA of $42.8 million, or 30.8% of revenue.
View on SEC.gov

Browse all earnings releases →

VERACYTE, INC. filing history →

Source: SEC EDGAR
accession 0001384101-26-000029
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.